Endologix to Present at the 26th Annual Canaccord Adams Summer Seminar
August 02 2006 - 4:05PM
Business Wire
Endologix, Inc. (Nasdaq:ELGX) today announced that Paul McCormick,
president and chief executive officer, will make a presentation to
the investment community at the 26th Annual Canaccord Adams Summer
Seminar on Tuesday, August 8, 2006 at 8:30 a.m. Eastern time (5:30
a.m. Pacific time) at the Boston Marriott Long Wharf Hotel.
Interested investors may gain access to a live audio webcast and
slide presentation via the Internet by visiting the Company's Web
site at www.endologix.com. The presentation will be available and
archived on the Web site for 30 days. About Endologix Endologix,
Inc. develops and manufactures minimally invasive treatments for
vascular diseases. Endologix's Powerlink System is an endoluminal
stent graft (ELG) for treating abdominal aortic aneurysms (AAA).
AAA is a weakening of the wall of the aorta, the largest artery in
the body, resulting in a balloon-like enlargement. Once AAA
develops, it continues to enlarge and, if left untreated, becomes
increasingly susceptible to rupture. The overall patient mortality
rate for ruptured AAA is approximately 75%, making it the
thirteenth leading cause of death in the U.S. Additional
information can be found on Endologix's Web site at
www.endologix.com.
Endologix (NASDAQ:ELGX)
Historical Stock Chart
From Jun 2024 to Jul 2024
Endologix (NASDAQ:ELGX)
Historical Stock Chart
From Jul 2023 to Jul 2024